Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,016.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.196%)
Market Cap: £145.79b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Buyback programme: transactions 27Feb-4Mar

5 Mar 2026 11:16

RNS Number : 5191V
Banco Santander S.A.
05 March 2026

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

Reference is made to our notice of inside information of 4 February 2026 (official registry number 3077) (the "Buyback Commencement Communication"), relating to the buyback programme of own shares (the "Buyback Programme") approved by the Board of Directors of Banco Santander.

Pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Bank informs of the transactions carried out over its own shares between 27 February and 4 March (both inclusive).

The cash amount of the shares purchased to 4 March 2026 as a result of the execution of the Buyback Programme amounts to 1,816,349,835 Euros, which represents approximately 36.1% of the maximum investment amount of the Buyback Programme. The programme was announced together with its other characteristics through the Buyback Commencement Communication. With these purchases, the Bank has repurchased approximately 16.3% of its outstanding shares as of 2021.

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (?)

27/02/2026

SAN

Purchase

XMAD

5,000,000

10.8788

02/03/2026

SAN

Purchase

XMAD

5,000,000

10.3017

02/03/2026

SAN

Purchase

CEUX

2,000,000

10.3022

03/03/2026

SAN

Purchase

XMAD

5,000,000

9.5657

03/03/2026

SAN

Purchase

CEUX

3,000,000

9.5663

04/03/2026

SAN

Purchase

XMAD

4,084,830

9.8929

TOTAL

24,084,830

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

Detailed information of the transactions carried out within the referred period is attached as Annex I.

Boadilla del Monte (Madrid), 5 March 2026

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 27/02/2026 and 04/03/2026 (both inclusive)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSAKPBDDBKDQNK
Date   Source Headline
24th Apr 20187:00 amRNS1Q2018 results press release
24th Apr 20187:00 amRNSMerger by absorption agreement of Banco Popular
24th Apr 20187:00 amRNS1Q2018 results report & analyst presentation
23rd Apr 20183:02 pmRNS1Q2018 results presentation
17th Apr 20185:27 pmRNSUpward revision of the rating by Moody´s
17th Apr 20184:42 pmRNSDirector/PDMR Shareholding
17th Apr 20184:36 pmRNSDirector/PDMR Shareholding
17th Apr 20184:18 pmRNSDirector/PDMR Shareholding
17th Apr 20184:17 pmRNSDirector/PDMR Shareholding
12th Apr 20184:47 pmRNSUpward revision of the rating by DBRS
9th Apr 20188:25 amRNSUpward revision of the rating by S&P
26th Mar 20187:42 amRNSSale of the stake in WiZink
26th Mar 20187:00 amRNSDividend Declaration
23rd Mar 20181:44 pmRNS2018 AGM - Resolutions
23rd Mar 20181:38 pmRNS2018 AGM - Press release
15th Mar 20185:17 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSPreferred securities contingently convertible
12th Mar 20189:31 amRNSPre Stabilisation Notice
1st Mar 20186:03 pmRNSDirector/PDMR Shareholding
1st Mar 20186:02 pmRNSDirector/PDMR Shareholding
21st Feb 20185:03 pmRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Feb 20184:38 pmRNS2018 Notice of AGM
16th Feb 20184:34 pmRNS2017 Annual Financial Report
14th Feb 20187:01 amRNSAnnouncement: Notice of AGM
31st Jan 20187:00 amRNS2017 results report & analyst presentation
31st Jan 20187:00 amRNS2017 results press release
30th Jan 20182:59 pmRNS2017 results presentation
16th Jan 20184:44 pmRNSDirector/PDMR Shareholding
16th Jan 20184:41 pmRNSDirector/PDMR Shareholding
16th Jan 20184:40 pmRNSDirector/PDMR Shareholding
28th Dec 20173:50 pmRNSDirector/PDMR Shareholding
20th Dec 20177:18 amRNSInformation on dividends
18th Dec 20175:03 pmRNS2018 prudential minimum capital requirements
15th Dec 201712:15 pmRNSDirector/PDMR Shareholding
15th Dec 20177:33 amRNSFidelity Bonds: Results of the public tender offer
14th Dec 20177:29 amRNSAgreement with Deutsche Bank, A.G.
29th Nov 20177:00 amRNSChanges approved by the Board of Directors
24th Nov 20177:00 amRNSDirector/PDMR Shareholding
15th Nov 20174:44 pmRNSDirector/PDMR Shareholding
15th Nov 20174:40 pmRNSDirector/PDMR Shareholding
15th Nov 20174:39 pmRNSDirector/PDMR Shareholding
10th Nov 20173:29 pmRNSDirector/PDMR Shareholding
10th Nov 20173:28 pmRNSDirector/PDMR Shareholding
10th Nov 20173:28 pmRNSDirector/PDMR Shareholding
10th Nov 20173:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.